Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Overexpression of metabolic markers HK1 and PKM2 contributes to lymphatic metastasis and adverse prognosis in Chinese gastric cancer.

Literature DB >> 26464675

Overexpression of metabolic markers HK1 and PKM2 contributes to lymphatic metastasis and adverse prognosis in Chinese gastric cancer.

Yunshu Gao¹, Dongyun Xu², Guanzhen Yu³, Jun Liang⁴.

Abstract

Hexokinase 1 (HK1) and pyruvate kinase M2 (PKM2) are two key regulators in glycosis and oncogenic markers in cancers. In the present study, we investigated the expression profile by Western blotting and immunohistochemistry and determined their prognostic values in the gastric cancer. Expression of HK1 and PKM2 was remarkably increased in gastric cancer tissues and was significantly associated lymphatic metastasis and advanced TNM staging. In the COX regression model, HK1 and TNM stage were analyzed as adverse prognostic indicators in gastric cancer. Furthermore, patients with HK1 expression showed remarkable shorter survival duration in both lymphatic metastasis cohort and advanced staging cohort. Our results suggest that overexpression of PKM2 and HK1, especially the latter, significantly associates with lymphatic metastasis, advanced clinical staging and unfavorable prognosis in gastric cancer.

Entities: Chemical Disease Gene Species

Keywords: Gastric cancer; HK1; PKM2

Mesh：

Substances：

Year: 2015 PMID： 26464675 PMCID： PMC4583907

Source DB: PubMed Journal: Int J Clin Exp Pathol ISSN： 1936-2625

26 in total

1. On respiratory impairment in cancer cells.

Authors: O WARBURG
Journal: Science Date: 1956-08-10 Impact factor: 47.728

2. TNM: principles, history, and relation to other prognostic factors.

Authors: L H Sobin
Journal: Cancer Date: 2001-04-15 Impact factor: 6.860

3. c-Myc transactivation of LDH-A: implications for tumor metabolism and growth.

Authors: H Shim; C Dolde; B C Lewis; C S Wu; G Dang; R A Jungmann; R Dalla-Favera; C V Dang
Journal: Proc Natl Acad Sci U S A Date: 1997-06-24 Impact factor: 11.205

Review 4. Why do cancers have high aerobic glycolysis?

Authors: Robert A Gatenby; Robert J Gillies
Journal: Nat Rev Cancer Date: 2004-11 Impact factor: 60.716

5. Warburg effect revisited: an epigenetic link between glycolysis and gastric carcinogenesis.

Authors: X Liu; X Wang; J Zhang; E K Y Lam; V Y Shin; A S L Cheng; J Yu; F K L Chan; J J Y Sung; H C Jin
Journal: Oncogene Date: 2009-11-02 Impact factor: 9.867

Review 6. Aerobic glycolysis: a novel target in kidney cancer.

Authors: Brian Shuch; W Marston Linehan; Ramaprasad Srinivasan
Journal: Expert Rev Anticancer Ther Date: 2013-06 Impact factor: 4.512

7. miR-143 regulates hexokinase 2 expression in cancer cells.

Authors: A Peschiaroli; A Giacobbe; A Formosa; E K Markert; L Bongiorno-Borbone; A J Levine; E Candi; A D'Alessandro; L Zolla; A Finazzi Agrò; G Melino
Journal: Oncogene Date: 2012-04-02 Impact factor: 9.867

8. PKM2 as a biomarker for chemosensitivity to front-line platinum-based chemotherapy in patients with metastatic non-small-cell lung cancer.

Authors: C Papadaki; M Sfakianaki; E Lagoudaki; G Giagkas; G Ioannidis; M Trypaki; E Tsakalaki; A Voutsina; A Koutsopoulos; D Mavroudis; V Georgoulias; J Souglakos
Journal: Br J Cancer Date: 2014-09-18 Impact factor: 7.640

9. Novel association of HK1 with glycated hemoglobin in a non-diabetic population: a genome-wide evaluation of 14,618 participants in the Women's Genome Health Study.

Authors: Guillaume Paré; Daniel I Chasman; Alexander N Parker; David M Nathan; Joseph P Miletich; Robert Y Zee; Paul M Ridker
Journal: PLoS Genet Date: 2008-12-19 Impact factor: 5.917

Review 10. PKM2: the thread linking energy metabolism reprogramming with epigenetics in cancer.

Authors: Ling Chen; Ying Shi; Shuang Liu; Ya Cao; Xiang Wang; Yongguang Tao
Journal: Int J Mol Sci Date: 2014-06-26 Impact factor: 5.923

17 in total

1. Effect of lentivirus-mediated shRNA inactivation of HK1, HK2, and HK3 genes in colorectal cancer and melanoma cells.

Authors: Anna V Kudryavtseva; Maria S Fedorova; Alex Zhavoronkov; Alexey A Moskalev; Alexander S Zasedatelev; Alexey A Dmitriev; Asiya F Sadritdinova; Irina Y Karpova; Kirill M Nyushko; Dmitry V Kalinin; Nadezhda N Volchenko; Nataliya V Melnikova; Kseniya M Klimina; Dmitry V Sidorov; Anatoly Y Popov; Tatiana V Nasedkina; Andrey D Kaprin; Boris Y Alekseev; George S Krasnov; Anastasiya V Snezhkina
Journal: BMC Genet Date: 2016-12-22 Impact factor: 2.797

2. Overexpression of pyruvate kinase M2 predicts a poor prognosis for patients with osteosarcoma.

Authors: Zheng-Xuan Liu; Liang Hong; Song-Qing Fang; Guang-Hua Tan; Pei-Guan Huang; Zhi Zeng; Xue Xia; Xiao-Xu Wang
Journal: Tumour Biol Date: 2016-09-19

3. Pyruvate kinase M2 overexpression and poor prognosis in solid tumors of digestive system: evidence from 16 cohort studies.

Authors: Jiayuan Wu; Liren Hu; Manyu Chen; Wenjun Cao; Haicong Chen; Taiping He
Journal: Onco Targets Ther Date: 2016-07-14 Impact factor: 4.147

4. Pyruvate kinase isozyme M2 and glutaminase might be promising molecular targets for the treatment of gastric cancer.

Authors: Kishu Kitayama; Masakazu Yashiro; Tamami Morisaki; Yuichiro Miki; Tomohisa Okuno; Haruhito Kinoshita; Tatsunari Fukuoka; Hiroaki Kasashima; Go Masuda; Tsuyoshi Hasegawa; Katsunobu Sakurai; Naoshi Kubo; Kosei Hirakawa; Masaichi Ohira
Journal: Cancer Sci Date: 2017-11-27 Impact factor: 6.716